The Buck Institute, Insilico Medicine, and Juvenescence Found Napa Therapeutics to Develop Drugs to Impede Age-Related Disease
- Written by Reporters
Collaboration will harness AI technology to address an aging-related target
NOVATO, US - Media OutReach - August 14 , 2018 - The Buck Institute for Research on Aging, Insilico Medicine, and Juvenescence Ltd announced today that they have formed Napa Therapeutics, Ltd to develop drugs against a novel aging-related target. The Buck...

